Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

Overview of attention for article published in New England Journal of Medicine, November 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

news: 25 news outlets
blogs: 5 blogs
policy: 4 policy sources
twitter: 71 X users
patent: 47 patents
facebook: 5 Facebook pages

googleplus: 4 Google+ users
reddit: 2 Redditors
f1000: 1 research highlight platform
guideline: 18 clinical guideline sources
podcasts: 2 podcasts

Readers on

mendeley: 1273 Mendeley

So far, Altmetric has seen 35 news stories from 25 outlets.

The Stelara from Johnson

Ad Hoc News, 07 Jul 2026

By Nora Whitfield, ad hoc news New Launch Desk. Reviewed July 07, 2026, 4:31 PM ET.

Adalimumab induced psoriasis in a Crohn's disease patient: A case report.

The Free Library, 14 Jul 2024

Byline: Dhaifallah Alenizi Keywords: Adalimumab, psoriasis, Crohn's disease, paradoxical psoriasis.

EMA Approves Tx for Psoriasis and Other Autoimmune Disorders

Medscape, 23 Feb 2024

In its February 2024 meeting, the European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use has…

Behandlungskonzepte bei chronisch entzündlichen Darmerkrankungen

Deutsches Ärzteblatt, 10 Nov 2023

INTERNATIONAL STUDIEREN Behandlungskonzepte bei chronisch entzndlichen... Artikel Autoren Grafiken/Tabellen Literatur Kommentare…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 31 additional news stories.